Option chain shows key data for Tectonic Therapeutic's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Tectonic Therapeutic.

Tectonic Therapeutic (NASDAQ:TECX) Stock, Option Chain

Tectonic Therapeutic

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.

Nasdaq index

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CRGX

NTCT

TECX

Nasdaq Moves Lower; Meta Platforms Posts Strong Sales

IBM’s Quantum Computing Leadership

Movers

ACMR

BFLY

CALX

CHKP

CRDO

SMTC

IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday

Wall Street_Dow

AMOD

CLEU

SLXN

TSLA

Dow Jumps Over 100 Points; Tesla Earnings Miss Views

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic Inc

Health Care

Press Releases

Tectonic Therapeutic to Participate in September Investor Conferences

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

General

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Tectonic Announces $185 Million Private Placement

Tectonic Therapeutic to Participate in March Investor Conferences

Abivax

Akebia Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

AnaptysBio

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Erasca

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Humacyte

Keros Therapeutics

MeiraGTx Hldgs

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Oruka Therapeutics

PureTech Health plc - American Depositary Shares

PureTech Health

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Sage Therapeutics

Solid Biosciences

Stoke Therapeutics

Savara

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Upstream Bio

Wells Fargo

Raymond James

Leerink Partners

Piper Sandler

Comments

Tectonic Therapeutic

Tectonic Therapeutic (TECX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga